Aquestive Therapeutics (AQST) Assets Average (2018 - 2025)
Historic Assets Average for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $128.6 million.
- Aquestive Therapeutics' Assets Average rose 1304.87% to $128.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.6 million, marking a year-over-year increase of 1304.87%. This contributed to the annual value of $79.4 million for FY2024, which is 3874.12% up from last year.
- Aquestive Therapeutics' Assets Average amounted to $128.6 million in Q3 2025, which was up 1304.87% from $98.0 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Assets Average ranged from a high of $128.6 million in Q3 2025 and a low of $54.1 million during Q3 2022
- In the last 5 years, Aquestive Therapeutics' Assets Average had a median value of $63.6 million in 2021 and averaged $77.9 million.
- Per our database at Business Quant, Aquestive Therapeutics' Assets Average skyrocketed by 10893.65% in 2024 and then tumbled by 2071.64% in 2025.
- Aquestive Therapeutics' Assets Average (Quarter) stood at $63.6 million in 2021, then dropped by 14.43% to $54.5 million in 2022, then grew by 7.3% to $58.4 million in 2023, then surged by 80.88% to $105.7 million in 2024, then increased by 21.7% to $128.6 million in 2025.
- Its Assets Average stands at $128.6 million for Q3 2025, versus $98.0 million for Q2 2025 and $101.8 million for Q1 2025.